Normalization of the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats Via Somatostatin Type 2 Receptor Antagonism

被引：0
|
作者：
Yue, Jessica T. Y.
Burdett, Elena
Coy, David H.
Efendic, Suad
Vranic, Mladen
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A35 / A35
页数：1
相关论文
共 50 条
  • [1] Somatostatin type 2 receptor antagonism improves glucagon and corticosterone counterregulation to hypoglycaemia in STZ-diabetic rats
    Yue, J. T. Y.
    Burdett, E.
    Coy, D. H.
    Efendic, S.
    Vranic, M.
    DIABETOLOGIA, 2009, 52 : S236 - S237
  • [2] Subcutaneous Administration of the Novel Somatostatin Receptor 2 Antagonist ZT-01 Restores the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats to Normal Levels
    Farhat, Rawad
    Simonson, Eric
    Riddell, Michael
    Liggins, Richard
    Chan, Owen
    DIABETES, 2020, 69
  • [3] Novel Somatostatin Receptor 2 Antagonist ZT-01 Prevents Hypoglycemia Onset in STZ-Diabetic Rats by Improving Glucagon Secretion
    Aiken, Julian
    D'Souza, Ninoschka C.
    Simonson, Eric
    Farhat, Rawad
    Chan, Owen
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2020, 69
  • [4] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2010, 59 : A205 - A206
  • [5] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Riddell, Michael C.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2013, 62 (07) : 2215 - 2222
  • [6] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
    Karimian, Negar
    Qin, Tairan
    Liang, Tao
    Osundiji, Mayowa
    Huang, Yachi
    Teich, Trevor
    Riddell, Michael C.
    Cattral, Mark S.
    Coy, David H.
    Vranic, Mladen
    Gaisano, Herbert Y.
    DIABETES, 2013, 62 (08) : 2968 - 2977
  • [7] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter regulatory Response to Hypoglycemia in Type 1 Diabetes BB Rats
    Qin, Tairan
    Karimian, Negar
    Osundiji, Mayowa
    Huang, Yachi
    Coy, David H.
    Vranic, Mladen
    Gaisano, Herbert Y.
    DIABETES, 2012, 61 : A47 - A47
  • [8] Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Giacca, Adria
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2012, 61 (01) : 197 - 207
  • [9] Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats
    Hoffman, Emily G.
    Dsouza, Ninoschka
    Aiken, Julian
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2021, 70
  • [10] PANCREATIC-ISLET CELLS TRANSPLANTATION AS A METHOD OF BLOOD-GLUCOSE NORMALIZATION IN STZ-DIABETIC RATS
    WOJCIKOWSKI, C
    ARENDARCZYK, W
    PRZEPIERA, E
    DRUZYNSKA, J
    GEMBAL, M
    DIABETOLOGIA, 1993, 36 : A187 - A187
12345